Advances in the treatment of Raynaud's phenomenon.
Raynaud's phenomenon is a common condition characterized by vasospasm of the digital arteries and resulting cyanosis and redness. It often does not require pharmacologic management, but in some cases symptoms are severe and pharmacologic management is necessary. Calcium channel blockers are often used first-line, but in some patients are ineffective. Patients with severe symptoms or intolerance to available therapies have prompted exploration of alternative therapies, including endothelin antagonists, phosphodiesterase-5 inhibitors, antioxidants, newer vasodilators, statins, and botulinum toxin. These newer therapies provide the focus for this review.
Levien
Terri L
TL
College of Pharmacy, Washington State University Spokane, WA, USA. levient@wsu.edu
D000975:Antioxidants / Q000627:therapeutic use; D000077300:Bosentan; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D065128:Endothelin Receptor Antagonists; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D016285:Iloprost / Q000627:therapeutic use; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use; D011928:Raynaud Disease / Q000188:drug therapy*; D012702:Serotonin Antagonists / Q000627:therapeutic use; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000975:Antioxidants; D000077300:Bosentan; D019274:Botulinum Toxins, Type A; D002121:Calcium Channel Blockers; D065128:Endothelin Receptor Antagonists; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D016285:Iloprost; D058986:Phosphodiesterase 5 Inhibitors; D012702:Serotonin Antagonists; D017367:Selective Serotonin Reuptake Inhibitors; D013449:Sulfonamides; D014665:Vasodilator Agents
J Rheumatol. 2009 Jul;36(7):1550-2
19567637
Microvasc Res. 2005 May;69(3):178-9
15896360
Arthritis Rheum. 2009 Mar;60(3):870-7
19248104
Ann Rheum Dis. 1991 Nov;50(11):800-4
1722967
J Rheumatol. 2006 Sep;33(9):1918-9
16960964
Arthritis Rheum. 2004 Dec;50(12):3985-93
15593188
Ann Rheum Dis. 1985 Nov;44(11):754-60
3904643
J Rheumatol. 2001 Oct;28(10):2257-62
11669166
Arthritis Rheum. 2003 Jan;48(1):282-3; author reply 283
12528146
Lancet. 1982 Jan 9;1(8263):76-7
6119495
J Am Coll Cardiol. 2002 Oct 2;40(7):1232-40
12383570
J Rheumatol. 2008 Sep;35(9):1830-7
18634152
J Int Med Res. 2000 Nov-Dec;28(6):258-68
11191719
Rheumatol Int. 2007 Apr;27(6):599-601
17103176
Clin Pharmacol Ther. 2007 Apr;81(4):503-9
17301734
J Rheumatol. 2009 Oct;36(10):2264-8
19755613
Arch Dermatol. 2005 Jul;141(7):831-3
16027296
Postgrad Med J. 1986 Jan;62(723):15-8
3099273
Ann Intern Med. 1994 Feb 1;120(3):199-206
7506013
Br J Rheumatol. 1998 Sep;37(9):952-60
9783759
Rheumatology (Oxford). 2005 Feb;44(2):145-50
15546967
Rheumatology (Oxford). 2001 Sep;40(9):1038-43
11561116
Ann Med Interne (Paris). 2000 Sep;151(5):424-5
11033481
Rheumatology (Oxford). 2008 Apr;47(4):464-6
18263597
Eur J Clin Invest. 2004 Apr;34(4):312-3
15086364
Cochrane Database Syst Rev. 2000;(2):CD000953
10796395
J Rheumatol. 2005 Dec;32(12):2440-2
16331780
Plast Reconstr Surg. 2007 Jan;119(1):217-226
17255677
Cochrane Database Syst Rev. 2008 Apr 16;(2):CD006687
18425964
Rheumatology (Oxford). 2006 Aug;45(8):999-1004
16484290
Arthritis Rheum. 1998 Apr;41(4):670-7
9550476
Rheumatology (Oxford). 2003 Apr;42(4):601-2
12649412
Minerva Cardioangiol. 1999 May;47(5):137-43
10479851
Vasc Med. 2005 Nov;10(4):293-307
16444858
Angiology. 1993 Feb;44(2):161-3
8434812
N Engl J Med. 2002 Sep 26;347(13):1001-8
12324557
J Rheumatol. 2008 Sep;35(9):1801-8
18709692
Rheumatology (Oxford). 2004 Feb;43(2):229-33
12923288
Rheumatology (Oxford). 2004 Nov;43(11):1454-6
15502001
Rheumatology (Oxford). 2007 Feb;46(2):363-4
17116656
Ann Rheum Dis. 1988 Jan;47(1):43-7
2449871
Angiology. 1996 Sep;47(9):901-3
8810657
J Urol. 2004 Apr;171(4):1630
15017241
Clin Rheumatol. 2002 Jun;21(3):244-50
12111631
Hautarzt. 2008 Mar;59(3):230-2
17618409
Eur J Clin Pharmacol. 2003 Feb;58(10):717
12610751
J Hand Surg Am. 2009 Mar;34(3):446-52
19258141
Ann Rheum Dis. 2004 Nov;63(11):1522-4
15479910
Circulation. 2005 Nov 8;112(19):2980-5
16275885
Int J Neuropsychopharmacol. 2005 Jun;8(2):307-8
15569398
Scand J Rheumatol. 2011;40(4):323-5
21639825
Ann Rheum Dis. 1995 Mar;54(3):197-200
7538285
Arthritis Rheum. 1999 Dec;42(12):2646-55
10616013
Biol Psychiatry. 1997 Jun 15;41(12):1218-21
9171912
Ryumachi. 1998 Jun;38(3):504-10
9721558
Ann Intern Med. 2003 Nov 18;139(10):871-3
14623635
BMJ. 1989 Mar 4;298(6673):561-4
2467711
Ann Rheum Dis. 2010 Aug;69(8):1475-8
19900936
Clin Exp Rheumatol. 2001 Sep-Oct;19(5):503-8
11579708
Br J Rheumatol. 1988 Jun;27(3):220-6
2454140
Rheumatology (Oxford). 2010 Dec;49(12):2420-8
20837499
Ann Rheum Dis. 2005 Sep;64(9):1387
16100356
J Rheumatol. 1992 Sep;19(9):1407-14
1279170
Med Clin (Barc). 2004 Apr 10;122(13):501-4
15104947
Int J Immunopathol Pharmacol. 2005 Oct-Dec;18(4):761-70
16388726
Presse Med. 2006 Apr;35(4 Pt 1):587-92
16614599
Rheumatol Int. 2009 May;29(7):769-75
19037604
Br J Rheumatol. 1995 Jul;34(7):636-41
7670782
Clin Exp Dermatol. 2005 Jul;30(4):451
15953103
Arthritis Rheum. 2001 Aug;44(8):1841-7
11508437
J Rheumatol. 1996 Nov;23(11):1917-20
8923366
Rheumatology (Oxford). 2006 Oct;45 Suppl 3:iii45-8
16987835
Ann Rheum Dis. 2007 Oct;66(10):1398-9
17881663
Cochrane Database Syst Rev. 2000;(2):CD000956
10796398
Rheumatology (Oxford). 2006 Jul;45(7):911-2
16531439
J Am Acad Dermatol. 2008 Oct;59(4):633-53
18656283
J Cutan Med Surg. 2008 Jul-Aug;12(4):189-93
18627700
Arch Intern Med. 2006 Jan 23;166(2):231-3
16432094
J Rheumatol. 1992 Sep;19(9):1403-6
1279169
Arthritis Rheum. 2007 Jun;56(6):1985-93
17530638